The company's core activity is the development, manufacture and marketing of biopharmaceutical products, including active pharmaceutical ingredients (APIs), vaccines and finished dosage forms (FDFs), as well as the production of biotechnological medicines for the manufacture of monoclonal antibodies and vaccines.
AI-generated
Comparisons
MABXIENCE SA in comparison
Soon
Industry comparisons are coming soon
We're preparing industry comparisons that rank MABXIENCE SA by reviews, experience and specialisations.
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.